EMA takes positive stance on Moderna COVID-19 vaccine for adolescents
The European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use has taken a positive position on marketing authorization for Moderna's COVID-19 vaccine for use in adolescents 12 years of age and older. Read More
Machine learning predicts if a COVID-19 clinical trial will be successful
Using machine learning, researchers have teased out the underlying factors of success for COVID-19 clinical trials, according to a PLOS One article published on July 12. The analysis showed that drug features and study keywords are the most informative features of COVID-19 trials. Read More
Africa to get doses of Pfizer-BioNTech COVID-19 vaccine
Pfizer and BioNTech have signed a letter of intent with South Africa-based Biovac Institute to manufacture and distribute the companies' COVID-19 vaccine within the African Union. Read More
Tetherex licenses adenovirus vaccine platform from Mayo Clinic
Tetherex Pharmaceuticals has obtained an exclusive worldwide license for the development and commercialization of a novel single-cycle adenovirus vaccine platform from the Mayo Clinic. The platform will be used to target multiple infectious diseases beginning with a COVID-19 vaccine. Read More
With Hitachi deal done, Fujifilm sets sights on healthcare growth
Fresh off its acquisition of Hitachi's medical imaging business, Japanese industrial giant Fujifilm on July 1 rebranded its healthcare subsidiaries in the U.S. and Europe to reflect the newly integrated company. The deal exemplifies Fujifilm's plan to make healthcare its primary business. Read More
Cenexi to manufacture OSE's COVID-19 vaccine
Cenexi signed a deal agreeing to manufacture clinical batches of CoVepiT, OSE Immunotherapeutics' COVID-19 vaccine candidate, which will be used in the product's development phases. Read More
FDA issues EUA for monoclonal antibody for treatment of hospitalized COVID-19 patients
The U.S. Food and Drug Administration (FDA) has issued an emergency use authorization (EUA) to Genentech, a member of the Roche Group, for tocilizumab (Actemra) for the treatment of hospitalized adults and pediatric patients. Read More
New in vitro models offer effective way to study respiratory viruses
A new accessible and scalable protocol for manufacturing in vitro lung cell models could have applications in the development of new therapies for respiratory viral infections and drug toxicology studies on human lungs. Details about the protocol were published in Stem Cells on June 21. Read More
Enochian gets license for inhaled treatment tech
Enochian BioSciences has acquired a license for technology that can potentially treat and prevent all variants of the coronavirus as well as influenza. Read More
New AI model could predict viral jumps from animals to humans
A new artificial intelligence (AI)-based computational model called SweetNet aimed at characterizing complex carbohydrates could help predict which viruses are likely to spread from animals to humans. The details of the research were published in Cell Reports on June 15. Read More
Connect
Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter